Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 318

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 318
---
AT excluded) None of AF’s fee was contingent on the consummation of the Business Combination and AF provided no previous services to the parties to the Business Combination Agreement or their affiliates. In connection with the services rendered by Ghilin for the December 2022 and the January 2023 valuation reports, OSR Holdings paid Ghilin a total amount of KRW 35,200,000 (V.A.T. included). OSR Holdings did not commission or pay Avance for the 2020 valuation report it produced. The report was prepared for Vaximm prior to OSR Holdings’ acquisition of Vaximm. Vaximm paid Avance CHF 13,086 for the 2020 valuation report. 189 Interests of BLAC’s Directors and Executive Officers in the Business Combination When you consider the recommendation of the BLAC Board in favor of approval of the Business Combination Proposal, you should keep in mind that BLAC’s directors and officers have interests in the Business Combination that are different from, or in addition to, your interests as a stockholder. These interests include, among other things: •the fact that the Sponsor has agreed not to redeem any shares of BLAC Common Stock held by it in connection with a stockholder vote to approve a proposed initial business combination (the Sponsor was not granted any consideration or incentive to agree not to redeem any shares of BLAC Common Stock held by it in connection with a stockholder vote to approve the Business Combination); •the fact that the Sponsor paid an aggregate of $25,000 (or $0.014 per share) for 1,725,000shares of BLAC Common Stock, which will have a significantly higher value at the time of the Business Combination. If unrestricted and freely tradable, such shares would have had an aggregate market value of $20,010,000 based upon the closing price of $11.60 per share of BLAC Common Stock on Nasdaq on January27, 2025, the most recent practicable date prior to the date of this proxy statement and an aggregate market value of $20,010,000 based upon the closing price of $11.60 per share of BLAC Common Stock on Nasdaq on January27, 2025, the Record Date, but given the restrictions on those shares, we believe those shares have less value; •the fact that Sponsor purchased 430,000 private placement units (including the underlying securities) for an aggregate purchase price of $4,300,000 (or $10